Cargando…
The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients
The majority of lung cancers belong to the non-small-cell lung cancer (NSCLC) category, which is linked to a high mortality rate despite significant progress in diagnosis and treatment. Therefore, there is a need for novel prognostic NSCLC biomarkers to improve prognosis which currently remains poor...
Autores principales: | Özdede, Murat, Taban, Hakan, Akman, Orkun, Önder, Sevgen, Kılıçkap, Saadettin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517341/ https://www.ncbi.nlm.nih.gov/pubmed/37746394 http://dx.doi.org/10.7759/cureus.44016 |
Ejemplares similares
-
KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
por: Liu, Yi-Zhen, et al.
Publicado: (2016) -
Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023) -
Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report
por: Taban, Hakan, et al.
Publicado: (2022) -
High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma
por: Xu, Yongzheng, et al.
Publicado: (2020) -
Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC
por: Jiang, Yu-Juan, et al.
Publicado: (2022)